Actelion nominates Garnier and Bertolin
This article was originally published in Scrip
Executive Summary
In the latest round in the battle to control Actelion, the incumbent board has nominated industry veterans Jean-Pierre Garnier and Robert Bertolini for election to the company's board of directors at the 2011 annual general meeting of shareholders, to be held on 05 May 2011. If elected, Garnier, formerly CEO of GlaxoSmithKline, will become vice chairman of the board with a view to him taking over as chairman when Robert Cawthorne stands down at the 2012 AGM. Mr. Bertolini, is the former CFO of Schering-Plough, now part of Merck.